RESUMO
Laryngopharyngeal reflux (LPR) may contribute to the development of laryngeal diseases including vocal fold leukoplakia. Clinical methods of determining LPR are limited. Pepsin, as an exogenous protein, is considered as a biomarker of LPR. The aim of the current study was, therefore, to detect pepsin by immunohistochemistry in the biopsies from patients with vocal fold leukoplakia, and by which, to determine the potential association of LPR and vocal leukoplakia. A total of 26 biopsies from patients with vocal fold leukoplakia were examined in comparison with 20 vocal fold biopsies from control subjects. We found that 2 out of 26 patients (7.7%) were strongly positive, 4 of the 26 (15.4%) patients were positive, 11 of the 26 (42.3%) patients were weakly positive, and 9 of the 26 (34.6%) were negative staining for pepsin. In contrast, only 4 of the 20 (20.0%) control subjects were weakly positive and the rest (16; 80.0%) were negative staining for pepsin. There was significant difference between the two groups in terms of positivity of pepsin staining (χ2 = 24.181, P <0.001). These findings suggest that pepsin immunohistochemical staining could be a biomarker of LPR and that LPR may be a risk factor for the development of vocal fold leukoplakia.
Assuntos
Imuno-Histoquímica , Refluxo Laringofaríngeo/enzimologia , Leucoplasia/enzimologia , Pepsina A/análise , Prega Vocal/enzimologia , Biomarcadores/análise , Biópsia , Distribuição de Qui-Quadrado , Humanos , Refluxo Laringofaríngeo/complicações , Refluxo Laringofaríngeo/patologia , Leucoplasia/etiologia , Leucoplasia/patologia , Projetos Piloto , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Risco , Prega Vocal/patologiaRESUMO
AIM: To compare cyclooxygenase 2 expression (COX2-E) between normal, oral leukoplakia lesions and different grades of oral squamous cell carcinoma (SCC). MATERIALS AND METHODS: Around 90 paraffin embedded blocks consisting of 45 SCC, 15 leukoplakia and 17 controls were selected for immunohistochemistry (IHC) for detection of COX2- E. COX2-E was divided in four grades, as A (0-10%), B (11- 40%), C (41-70%) and D (< 70%) cellularity. RESULTS: Mean age of the patients was 55.17 ± 18.41 (M:57.92 ± 16.87, F:52.19 ± 19.74). A significant difference was found in COX2 expression between SCC total and, basal and spinous layers of leukoplakia (p > 0.05). COX2-E in spinous layer of normal tissue was significantly lower than SCC (p = 0.000). COX2-E was significantly different in SCC grade 3 and leukoplakia (p = 0.001) and normal tissue (p = 0.000). COX2-E was significantly higher in SCC grade 3 compared to leukoplakia (basal layer) (p = 0.000). CONCLUSION: We showed a significant higher COX2-E in SCC lesions compared to leukoplakias and normal controls. In our study COX2-E was not significantly different in SCC grades 1, 2 and 3 (p < 0.05).
Assuntos
Carcinoma de Células Escamosas/enzimologia , Ciclo-Oxigenase 2/biossíntese , Leucoplasia/enzimologia , Mucosa Bucal/enzimologia , Neoplasias Bucais/enzimologia , Adulto , Idoso , Carcinoma de Células Escamosas/patologia , Ciclo-Oxigenase 2/genética , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/patologia , Gradação de Tumores , Inclusão em Parafina , Estatísticas não ParamétricasRESUMO
Multiple tobacco smoke-related premalignant and malignant lesions develop synchronously or metachronously in various organ sites, including the oral cavity. Both field cancerization and clonal migration seem to contribute to the occurrence of multiple tumors. Although the importance of endogenous factors (e.g., oncogenes) in regulating clonal migration is well established, little is known about the role of exogenous factors. Hence, the main objective of this study was to elucidate the mechanism by which tobacco smoke stimulated the migration of cells through extracellular matrix (ECM). Treatment of MSK-Leuk1 cells with a saline extract of tobacco smoke induced the migration of cells through ECM. Tobacco smoke induced the expression of urokinase-type plasminogen activator (uPA), resulting in plasmin-dependent degradation of ECM and increased cell migration. AG1478, a small-molecule inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, a neutralizing antibody to EGFR, or an antibody to amphiregulin, an EGFR ligand, also blocked tobacco smoke-mediated induction of uPA and cell migration through ECM. PD98059, an inhibitor of mitogen-activated protein kinase (MAPK) kinase activity, caused similar inhibitory effects. Taken together, these results suggest that tobacco smoke activated the EGFR-->extracellular signal-regulated kinase 1/2 MAPK pathway, causing induction of uPA. This led, in turn, to increased plasmin-dependent degradation of matrix proteins and enhanced cell migration through ECM. These data strongly suggest that chemicals in tobacco smoke can mimic the effects of oncogenes in regulating uPA-dependent cell invasion through ECM. These findings also strengthen the rationale for determining whether inhibitors of EGFR tyrosine kinase reduce the risk of tobacco smoke-related second primary tumors.
Assuntos
Movimento Celular , Receptores ErbB/metabolismo , Leucoplasia/enzimologia , Leucoplasia/patologia , Nicotiana , Fumaça , Ativador de Plasminogênio Tipo Uroquinase/biossíntese , Indução Enzimática , Humanos , Queratinócitos/patologia , Leucoplasia/etiologia , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Transdução de Sinais , Ativador de Plasminogênio Tipo Uroquinase/genética , Ativador de Plasminogênio Tipo Uroquinase/metabolismoRESUMO
BACKGROUND: Cyclooxygenase (COX) is the key regulatory enzyme in prostaglandin (PG) synthesis and is up-regulated in many premalignant and malignant lesions. The aim of this study was to investigate the in vitro DNA protective or damaging effects of COX-2 inhibitors using the single-cell gel electrophoresis (Comet) assay. MATERIALS AND METHODS: Cells from miniorgan cultures of pharyngeal mucosa from 30 patients were incubated once or five times with the COX-2 inhibitors celecoxib and rofecoxib. After treatment with H2O2, DNA fragmentation was determined. RESULTS: DNA strand-breaks were significantly reduced in cells pre-incubated with COX-2 inhibitors. Repeated incubation with celecoxib showed the strongest effect. This direct influence on DNA repair could be excluded by implementing DNA repair steps into the Comet assay. CONCLUSION: The findings suggest that, in addition to the known influence of COX-2 inhibitors on immune surveillance, neo-angiogenesis and cell proliferation, these substances may express a direct antimutagenic effect in conditions of oxidative stress.
Assuntos
Inibidores de Ciclo-Oxigenase 2/farmacologia , Dano ao DNA/efeitos dos fármacos , Lactonas/farmacologia , Lesões Pré-Cancerosas/enzimologia , Lesões Pré-Cancerosas/genética , Pirazóis/farmacologia , Sulfonamidas/farmacologia , Sulfonas/farmacologia , Celecoxib , Ensaio Cometa , Neoplasias de Cabeça e Pescoço/enzimologia , Neoplasias de Cabeça e Pescoço/genética , Humanos , Peróxido de Hidrogênio/farmacologia , Laringite/enzimologia , Laringite/genética , Leucoplasia/enzimologia , Leucoplasia/genética , Mucosa Bucal/efeitos dos fármacos , Mucosa Bucal/enzimologia , Mucosa Bucal/patologia , Estresse Oxidativo/efeitos dos fármacos , Faringe/efeitos dos fármacos , Faringe/enzimologia , Faringe/patologiaRESUMO
OBJECTIVE: To measure the lipid peroxidation and endogenous antioxidant enzyme status in oral carcinoma and the protective role of exogenous antioxidants. MATERIAL AND METHODS: 20 new cases of histologically proven oral squamous cell carcinoma, 20 of leukoplakia and 20 age and sex matched healthy conrols were included. Intra oral pH of patients and controlled were measured by quantitative litmus paper test and serum was analysed for malonialdehyde (MDA), super oxide bismutase (SOD), catalase and glutathione peroxidase (GP). Patients with leukoplakia were treated with exogenous antioxidants for 3 months and the same were reassessed. RESULTS: Oral pH of oral cancer patients was neutral (PH-7) but that of leukoplakia and controls were mildly acidic (6.64 and 6.58 respectively). Serum malonialdehyde levels were highest in oral cancer group. With antioxidant enzymes super oxide bismutase, catalase and glutathione peroxidase different pattern was noticed. Antioxidant enzymes remained almost the same (P > 0.005 each) in patients with leukoplakia after 3 months of vitamin A,C and E. but there was marginal increase in catalase level (P<0.05). CONCLUSION: This study shows the positive benefit of vitamin (A,C,E) and nutrition supplementation on the antioxidant enzyme defense system hence prevention of oral carcinogenesis in patients with leukoplakia.
Assuntos
Peroxidação de Lipídeos , Neoplasias Bucais/enzimologia , Oxirredutases/metabolismo , Antioxidantes/metabolismo , Carcinoma de Células Escamosas/enzimologia , Catalase/metabolismo , Glutationa Peroxidase/metabolismo , Humanos , Leucoplasia/enzimologia , Malondialdeído/metabolismo , Lesões Pré-Cancerosas/enzimologia , Superóxido Dismutase/metabolismoRESUMO
Oral cancer is the most common cancer in males and third most common in females in India, the main causative agent being the use of chewing tobacco with or without betel quid (BQ). However, nothing is known about the role of the host metabolic genes in oral cancer in ethnic Indian population. In this study, the prevalence of GSTM1 and GSTT1 null genotypes (GSTM1*2 and GSTT1*2) in oral premalignant leukoplakia cases and controls was ascertained in genomic DNA by a multiplex PCR technique. Biopsies taken from 98 oral leukoplakia patients and exfoliated cells from 82 healthy controls both of Indian ethnicity were analysed. GSTM1*1 (active) was present in 83% and GSTT1*1 (active) was present in 78% of all control subjects, while prevalence of GSTM1*2 and GSTT1*2 null genotypes was significantly higher among oral leukoplakia cases. The prevalence of GSTM1*2 in leukoplakia cases was 81.6% compared with 17% in controls [odds ratio (OR), 22; 95% confidence interval (CI), 1047] and GSTT1*2 was 75.5% in the cases versus 22% in controls (OR, 11; 95% CI, 5-22). Combined null genotypes of GSTM1 and GSTT1 prevailed in 60.2% of the cases with none detected in controls. Glutathione S-transferase M1 and T1 enzymes are both known to catalyse detoxification of reactive oxygen species, lipid peroxidation products and tobacco-derived carcinogens that have been found in the saliva of BQ/tobacco chewers. Our results, still requiring confirmation by a larger study, demonstrate that the null genotypes of both GSTM1 and GSTT1 increase with high penetrance, separately or in combination, the risk for developing leukoplakia in an Indian ethnic population.
Assuntos
Areca , Glutationa Transferase/genética , Leucoplasia/genética , Neoplasias Bucais/genética , Plantas Medicinais , Adulto , DNA de Neoplasias/análise , DNA de Neoplasias/genética , Feminino , Frequência do Gene , Genótipo , Humanos , Índia/epidemiologia , Leucoplasia/enzimologia , Leucoplasia/epidemiologia , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/enzimologia , Neoplasias Bucais/epidemiologia , Prevalência , Fatores de RiscoRESUMO
It is essential to identify intermediate marker endpoints of carcinogenesis for the evaluation of the effectiveness of cancer-chemopreventive agents. We have observed that levels of proteolytic activities (as detected by 4 different substrates) are increased 2-3-fold (P < 0.003) in oral buccal mucosa cells of smokers and patients with oral leukoplakia or erythroplakia as compared to a nonsmoking comparison group. In addition, proteolytic activity levels in the buccal cells were increased nearly 3-fold in patients with oral trauma (P < 0.01) or diabetes (P < 0.02), as well as pregnant women (P < 0.04). Excluding these subgroups of patients in epidemiological studies increase the differences in levels of proteolytic activities between both the nonsmoking comparison group and smokers and between the comparison group and patients with oral leukoplakia or erythroplakia. Evaluation of prerandomization levels of proteolytic activities of patients in cancer chemoprevention trials will increase the statistical power by allowing stratified randomization based on levels of proteolytic activities. The observed increases in levels of proteolytic activities in tissues at higher than normal risk of cancer development suggest that levels of proteolytic activities should be used as immediate marker endpoints in human cancer prevention trials using protease inhibitors as potential anticarcinogenic agents.
Assuntos
Leucoplasia/enzimologia , Mucosa Bucal/enzimologia , Neoplasias Bucais/enzimologia , Peptídeo Hidrolases/metabolismo , Administração Oral , Adolescente , Adulto , Idoso , Antineoplásicos/uso terapêutico , Carotenoides/uso terapêutico , Feminino , Humanos , Leucoplasia/etiologia , Leucoplasia/prevenção & controle , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/etiologia , Neoplasias Bucais/prevenção & controle , Estudos Prospectivos , Fumar/efeitos adversos , beta CarotenoRESUMO
The epithelial cells in squamous carcinoma and leukoplakia of the oral cavity possess the cell surface protease, guanidinobenzoatase (GB), in an active form. GB is closely similar to plasminogen activator, a protease associated with both transformed cells and tumour cells. The active centre of GB binds the fluorescent probe 9-aminoacridine (9-AA) enabling cells containing active GB to be visualised by fluorescent microscopy. It was observed that chemotherapy with cisplatin resulted in a marked decrease in cell surface GB activity and this decrease was due to the formation of an enzyme-inhibitor complex. One of the results of chemotherapy was shown to be the suppression of a cell surface protease which is known to be associated with migration and malignancy of cells in vivo.
Assuntos
Hidrolases de Éster Carboxílico/metabolismo , Carcinoma de Células Escamosas/tratamento farmacológico , Membrana Celular/enzimologia , Cisplatino/uso terapêutico , Endopeptidases/metabolismo , Neoplasias Bucais/tratamento farmacológico , Aminacrina , Carcinoma de Células Escamosas/enzimologia , Carcinoma de Células Escamosas/patologia , Epitélio/enzimologia , Epitélio/patologia , Formaldeído , Humanos , Cinética , Leucoplasia/enzimologia , Leucoplasia/patologia , Microscopia de Fluorescência , Mucosa Bucal/enzimologia , Neoplasias Bucais/enzimologia , Neoplasias Bucais/patologia , Inibidores de Proteases , Língua/enzimologiaAssuntos
Calicreínas/metabolismo , Neoplasias Bucais/enzimologia , Periodontite/enzimologia , Saliva/enzimologia , Carcinoma de Células Escamosas/enzimologia , Humanos , Inflamação , Leucoplasia/enzimologia , Mucosa Bucal/patologia , Mucosa Bucal/fisiopatologia , Glândula Parótida/metabolismo , Valores de ReferênciaRESUMO
The risk for a smoker of developing cancer of the larynx depends on the activity of the enzyme arylhydroxcarbonhydroxylase in his cells. The higher the genetically determined arylhydroxcarbonhydroxylase activity, the higher is the probability of developing the disease.
Assuntos
Hidrocarboneto de Aril Hidroxilases/sangue , Neoplasias Laríngeas/enzimologia , Lesões Pré-Cancerosas , Fumar , Doença Crônica , Indução Enzimática , Feminino , Humanos , Edema Laríngeo/enzimologia , Laringite/enzimologia , Leucoplasia/enzimologia , Linfócitos/enzimologia , Masculino , Espectrometria de FluorescênciaRESUMO
Activity of N-acetyl-beta-D-glucosaminidase, beta-glucuronidase, and acid phosphatase and myeloperoxidase was determined in neutrophils and lymphocytes of patients with cancer of the larynx and precancerous states of the larynx as well as--for comparative reasons--in patients with malignant tumors of female generation organs, breast carcinoma, cancer of the stomach and endometriosis. The main result of investigations performed was in fact that intracellular deficiency of beta-glucuronidase within the neutrophils characterizes patients with cancer and precancerous states of the larynx. Patients with cancer of the larynx show additionally a deficiency of neutrophil myeloperoxidase. Deficiency of N-acetyl-beta-D-glucosaminidase occurs, in contrast, in patients with malignancies of female generation organ. Activity of myeloperoxidase in neutrophils from patients with gastric carcinoma is slightly elevated.
Assuntos
Enzimas/deficiência , Neoplasias Laríngeas/enzimologia , Linfócitos/enzimologia , Neutrófilos/enzimologia , Acetilglucosaminidase/deficiência , Carcinoma de Células Escamosas/enzimologia , Endometriose/enzimologia , Feminino , Glucuronidase/deficiência , Humanos , Leucoplasia/enzimologia , Masculino , Papiloma/enzimologia , Peroxidase/deficiência , Lesões Pré-Cancerosas/enzimologia , Neoplasias Gástricas/enzimologia , Neoplasias do Colo do Útero/enzimologia , Neoplasias Uterinas/enzimologiaRESUMO
Cytochemical investigations performed in 24 men with precancerous states of the larynx, i.e. leukoplakia, papillomas and pachydermia, indicated that the peripheral blood neutrophils from these patients exhibit a significant intracellular deficiency of beta-glucuronidase activity and of total lipids, as well as an increased alkaline phosphatase activity. Acid phosphatase and N-acetyl-beta-glucosaminidase activities did not differ significantly between patients and normal controls. In the authors' opinion, the neutrophil beta-glucuronidase deficiency might be a specific disturbance of neutrophils in the precancerous states and the cancer of the larynx. The possible significance of this disturbance and the subsequent decrease of antitumor immune reactivity are discussed.